Found: 7
Select item for more details and to access through your institution.
An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor‐induced liver injury.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 7, p. 865, doi. 10.1111/apt.17898
- By:
- Publication type:
- Article
Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry.
- Published in:
- Liver International, 2024, v. 44, n. 9, p. 2303, doi. 10.1111/liv.15970
- By:
- Publication type:
- Article
Assessing the rate of non‐linkage to care and identifying barriers in individuals living with hepatitis B. Results of the LINK‐B study.
- Published in:
- Liver International, 2024, v. 44, n. 3, p. 706, doi. 10.1111/liv.15814
- By:
- Publication type:
- Article
Immune‐related hepatitis related to checkpoint inhibitors: Clinical and prognostic factors.
- Published in:
- Liver International, 2020, v. 40, n. 8, p. 1906, doi. 10.1111/liv.14489
- By:
- Publication type:
- Article
Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2024, v. 29, n. 3, p. 1, doi. 10.1016/j.aohep.2024.101489
- By:
- Publication type:
- Article
Increasing and sustaining blood-borne virus screening in Spain and Portugal throughout the COVID-19 pandemic: a multi-center quality improvement intervention.
- Published in:
- Frontiers in Public Health, 2024, p. 1, doi. 10.3389/fpubh.2023.1268888
- By:
- Publication type:
- Article
Unexpected long‐lasting anti‐HEV IgM positivity: Is HEV antigen a better serological marker for hepatitis E infection diagnosis?
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 7, p. 747, doi. 10.1111/jvh.13285
- By:
- Publication type:
- Article